Cell-Medicine News - LARVOL Sigma

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine
Retrospective data, Review: Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis. (Pubmed Central) - May 6, 2024
In addition, AFTV, peptide, and dendritic cell-based vaccines are among the most efficient vaccines for gliomas. Personalized vaccines also showed considerable efficacy for glioma treatments.

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine
B Long-Term Clinical Results Of 493 Cases Of Newly Diagnosed Glioblastoma And Survival Benefit By Combination With Pdt And Aftv, Aiming To Establish New Standard Treatment (Grote Zaal Foyer) - Sep 28, 2023 - Abstract #EANO2023EANO_294;
CONCLUSION The treatment results for glioblastoma have improved over the years. The combination of maximal tumor removal using iMRI, PDT and AFTV may aim for a 5-year survival rate of 50%.

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine
Biomarker, Journal: P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients. (Pubmed Central) - Jul 24, 2023
A p53-negative status in IHC and GTR were the predictive factors for AFTV treatment in newly diagnosed GBM patients. Microenvironment-targeted treatment and pretreatment blood cell status may be key factors to enhance therapy effects.

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine
TRANSITION OF LONG-TERM TREATMENT RESULTS OF 493 CASES OF NEWLY DIAGNOSED GLIOBLASTOMA AND SURVIVAL BENEFIT BY COMBINATION WITH PDT AND AFTV - AIMING TO ESTABLISH NEW STANDARD TREATMENT () - Sep 28, 2022 - Abstract #SNO2022SNO_477;
CONCLUSION The treatment results for glioblastoma have improved over the years. The combination of maximal tumor removal using iMRI, PDT and AFTV may aim for a 5-year survival rate of 50%.

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine
Retrospective data, Journal: Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis. (Pubmed Central) - Jul 30, 2021
In the multivariate analysis, GTR, proton therapy, and a combination of immunotherapies, including autologous formalin-fixed tumor vaccine, were the significant prognostic factors...In conclusion, GTR, proton therapy, and immunotherapy were good prognostic factors in single-center GBM cases. Tumor vaccine therapy for GTR cases achieved a notably high median survival time and long-term survival ratio, indicating its usefulness in GTR cases.

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine, Inc
This is true! #AFTVOUT (Twitter) - Feb 18, 2020

|||||||||| autologous formalin-fixed tumor vaccine - Cell / Medicine, Inc
Lol 99% of your tweets are about AFTV (Twitter) - Feb 13, 2020



	Diseases Companies Products Productz Mechanisms of Action Sites